TELA Bio, Inc.

04/23
|
$49.6 Million
Piper Sandler served as bookrunner for TELA Bio, Inc. on a confidentially marketed follow on offering
Sub-Type
CMFO
Sector
Healthcare
Sub-Sector
Med-Tech

Related Transactions

All Transactions
CompanionSpine
Senior Term Loan
Sole Placement Agent
$300.0 Million
Navalent
Nuvalent, Inc.
Follow-On Offering
Active Bookrunner
Scholar
Scholar Rock Holding Corporation
Confidentially Marketed Follow-On Offering
Active Bookrunner
$63.2 Million
ALX
ALX Oncology
Confidentially Marketed Follow-On Offering
Active Bookrunner
$258.7 Million
Biohaven Ltd.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$499.9 Million
Magrigal
Madrigal Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$322.0 Million
Immunovant
Immunovant, Inc.
Follow-On Offering
PIPE
Active Bookrunner
$350.0 Million
Crinetics
Crinetics Pharmaceuticals, Inc.
Follow-On Offering
Active Bookrunner
$258.7 Million
Cymabay
CymaBay Therapeutics, Inc.
Follow-On Offering
Active Bookrunner
$250.3 Million
Natera
Natera, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Quality
Vesey
QualityMetric Incorporated LLC
QualityMetric Incorporated, LLC, a portfolio compny of Vesey Street Capital Partners, has sold to an undisclosed buyer
Financial Advisor
BridgetoLife
TransMedics
Bridge to Life, Ltd.
Bridge to Life, Ltd. has sold EVOSS and LifeCradle perfusion technology assets to TransMedics
Financial Advisor
$149.9 Million
Procept
Procept Biorobotics Corp.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$60.0 Million
Inozyme
Inozyme Pharma, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$80.0 Million
Turnstone
Turnstone Biologics Inc.
Initial Public Offering
Active Bookrunner
Bluesight
Medacist
Thoma
Bluesight, Inc.
Financial Advisor

© 2023 Piper Sandler Companies. Since 1895. All rights reserved.